CV Sciences (CVSI) Capital Expenditures (2013 - 2026)

CV Sciences has disclosed Capital Expenditures across 12 years of filings, most recently posting $3000.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $3000.0, down 92.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $72000.0 (up 24.14% YoY), and the FY2025 annual result was $109000.0, up 505.56% from the prior year.
• Capital Expenditures came in at $3000.0 for Q1 2026 at CV Sciences, down from $9000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $49000.0 in Q2 2025 to a low of $3000.0 in Q1 2026.
• The 3-year median for Capital Expenditures is $14500.0 (2024), against an average of $21666.7.
• Across the five-year window, Capital Expenditures plunged 50.0% in 2025 and slumped 92.5% in 2026, its largest moves.
• CV Sciences' Capital Expenditures stood at $18000.0 in 2024, then slumped by 50.0% to $9000.0 in 2025, then slumped by 66.67% to $3000.0 in 2026.
• The last three Capital Expenditures figures came in at $3000.0 (Q1 2026), $9000.0 (Q4 2025), and $11000.0 (Q3 2025), per Business Quant data.